GlassScriptPhysician profile
Rose A Tempel
NPI 1730227398
$1,318.34
in general payments reported to CMS, 2019-2025
11 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $41.87 · 2023: $190 · 2024: $469 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $240.43 | 2024-2025 | Wegovy |
| Abbvie INC. | $229.27 | 2023-2024 | |
| Viiv Healthcare Company | $125.00 | 2024 | Apretude |
| Gilead Sciences, INC. | $122.20 | 2025 | Yeztugo |
| Kowa Pharmaceuticals America, INC. | $121.56 | 2025 | Zoryve |
| Bayer Healthcare Pharmaceuticals INC. | $120.15 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $118.24 | 2021 | |
| Phathom Pharmaceuticals, INC. | $99.33 | 2024 | Voquezna |
| Shield Therapeutics INC | $85.63 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $41.87 | 2022 | |
| Merck Sharp & Dohme LLC | $14.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Tempel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.